Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Brain Neoplasms 33Glioblastoma 32Melanoma 21Glioma 19Neuroblastoma 7Carcinoma, Renal Cell 6Carcinoma, Non-Small-Cell Lung 6Astrocytoma 6Ependymoma 5Colorectal Neoplasms 5Central Nervous System Neoplasms 5Recurrence 4Ovarian Neoplasms 4Medulloblastoma 4Lymphoma 4Carcinoma, Hepatocellular 4Thyroid Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Rhabdomyosarcoma 3Pancreatic Neoplasms 3Osteosarcoma 3Meningioma 3Lung Neoplasms 3Gliosarcoma 3Cholangiocarcinoma 3Carcinoma, Transitional Cell 3Vulvar Neoplasms 2Uterine Cervical Neoplasms 2Stomach Neoplasms 2Small Cell Lung Carcinoma 2

Interventions

Pemetrexed 20Bevacizumab 10Radiotherapy 8Spinal Puncture 7osimertinib 6Methotrexate 6Magnetic Resonance Spectroscopy 6aflutinib 5Topotecan 5Specimen Handling 5Trastuzumab 4Temozolomide 4Radiotherapy, Intensity-Modulated 4Dexamethasone 3trastuzumab deruxtecan 2pembrolizumab 2paclitaxel-Angiopep-2 conjugate 2omburtamab I-131 2merphos 2lorlatinib 2aumolertinib 2WP 744 2Vitamin B 12 2Rituximab 2Radiation 2Folic Acid 2Drug Therapy 2Cytarabine 2Cyclophosphamide 2Capecitabine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Meningeal Carcinomatosis × Nivolumab × CNS × Clear all
NCT02939300 2025-11-14

Ipilimumab and Nivolumab in Leptomeningeal Metastases

Massachusetts General Hospital

Phase 2 Completed
18 enrolled 17 charts
CNS

Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡